Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Zephyr Health Announces New Game Changing Solutions for Life Sciences Companies

Posted on: 30 Aug 16

SAN FRANCISCO, Aug. 30, 2016 (GLOBE NEWSWIRE) -- Zephyr Health, the leading Insights-as-a-Service solution provider to Life Sciences companies, today launched two new, game changing analytic capabilities for Zephyr IlluminateTM.  These new capabilities, Referral Analytics and Segment Analytics, previously available only for charter customers, are the latest addition to its enterprise solution that integrates thousands of disparate data sources to create precise and predictive insights.

Referral Analytics is the industry’s most innovative, machine-driven solution that identifies referral patterns to help predict and segment potential referring healthcare providers, specialists or organizations.  With Referral Analytics, life sciences companies can quickly compare historical referral trends and volume, and prioritize existing or new customers based upon referral potential.

Segment Analytics provides a summary view of multiple customer groups to better analyze and target key customers and markets. Using Zephyr Illuminate’s powerful, proprietary scoring capabilities, Segment Analytics aggregates data relevant to both medical and commercial teams on key attributes such as treatment, promotional engagement, marketing influence and clinical research.

“These new capabilities prove the transformational power big data has for a life sciences business,” said William King, Founder and Executive Chairman, Zephyr Health. “With these new capabilities our customers are significantly improving their outreach strategies by easily extracting these meaningful insights - like finding the highest ranking potential referrers, or high potential treaters with low engagement - all in Zephyr Illuminate’s simple user interface.”

Zephyr Illuminate™ was cited as a vertical specialist among insights solutions providers in the May 2016 Forrester Research Report, Vendor Landscape: Insights Service Providers. Fortune 100 life sciences companies are using Zephyr Illuminate to optimize product planning, launch and sales by engaging the right physicians, accounts and institutions using insights from global health data.

About Zephyr Health
Zephyr Health helps life sciences companies – pharmaceutical, biotech, medical device and diagnostics – engage the right physicians, accounts and institutions using insights from global health data. Zephyr Illuminate™ is a leading Insights-as-a-Service solution that integrates thousands of data sources to create precise and predictive insights. From pre-launch to product maturity, life sciences companies can make confident decisions faster with data-driven targeting and deep customer profiles. Zephyr Health's customers include Top 10 Pharmaceutical companies, Top 10 Biotech Companies and Top 10 Medical Device companies.

Zephyr Health is a privately held company headquartered in San Francisco with offices in London, UK, and Pune, India. Zephyr Health is venture backed by Google Ventures, Kleiner Perkins Caufield & Byers and Icon Ventures. For more information, please visit:


Last updated on: 31/08/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.